Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth.

In conclusion, activation of PP2A may provide a novel therapeutic target for neuroblastoma.
PMID: 30286326 [PubMed - as supplied by publisher]

Source: Translational Oncology - October 1, 2018 Category: Cancer & Oncology Authors: Williams AP, Garner EF, Waters AM, Stafman LL, Aye JM, Markert H, Stewart JE, Beierle EA Tags: Transl Oncol Source Type: research